Both studies propose that histone methyltransferase KMT1B has a critical role in the pathogenesis of NASH as it controls diet-induced hepatic inflammation through Sirt-1 and NFkB expression. The gene discussed is SIRT1; the disease is metabolic dysfunction-associated steatohepatitis.